Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Alkermes plc - Ordinary Shares
(NQ:
ALKS
)
40.03
-1.41 (-3.40%)
Delayed Quote
Updated: 2:57 PM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alkermes plc - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives.
↗
October 22, 2025
The companies are both working in the sleep space, focusing on excessive daytime sleepiness.
Via
Investor's Business Daily
Avadel Stock Rises After Acquisition Offer By Alkermes
↗
October 22, 2025
Alkermes will buy Avadel for up to $20 per share.
Via
Stocktwits
9 Analysts Assess Alkermes: What You Need To Know
↗
September 26, 2025
Analysts' ratings for Alkermes (NASDAQ: ALKS) over the last quarter vary from bullish to bearish, as provided by 9 analysts. The following table encapsulates their recent ratings, offering a glimpse...
Via
Benzinga
This Ciena Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
↗
September 26, 2025
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings...
Via
Benzinga
Deep Dive Into Alkermes Stock: Analyst Perspectives (7 Ratings)
↗
September 03, 2025
Via
Benzinga
Earnings Scheduled For July 29, 2025
↗
July 29, 2025
Via
Benzinga
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
↗
May 28, 2025
Via
Benzinga
Earnings Scheduled For May 1, 2025
↗
May 01, 2025
Via
Benzinga
NASDAQ:ALKS: good value for what you're paying.
↗
February 12, 2025
Uncover the potential of ALKERMES PLC, an undervalued stock. NASDAQ:ALKS maintains a strong financial position and offers an appealing valuation.
Via
Chartmill
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
↗
September 03, 2025
Via
Benzinga
This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
September 03, 2025
Via
Benzinga
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
September 03, 2025
Via
Benzinga
ALKERMES PLC (NASDAQ:ALKS) Emerges as a Top Value Pick with Strong Fundamentals and Undervalued Metrics
↗
August 05, 2025
ALKERMES PLC (ALKS) is a strong value stock with low P/E ratios, high profitability, and a debt-free balance sheet, making it an attractive pick for long-term investors.
Via
Chartmill
Earnings Scheduled For February 12, 2025
↗
February 12, 2025
Via
Benzinga
Alkermes PLC (NASDAQ:ALKS) Surges 7.8% Pre-Market After Q2 2025 Earnings Beat Revenue and EPS Estimates
↗
July 29, 2025
Alkermes PLC (ALKS) reported strong Q2 2025 results, beating revenue and EPS estimates, driving a 7.8% pre-market rally. The company reaffirmed full-year guidance, signaling confidence in growth.
Via
Chartmill
Topics
Earnings
Alkermes Q2 Sales Up 14 Percent
↗
July 29, 2025
Via
The Motley Fool
Topics
Intellectual Property
Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.
↗
July 21, 2025
All four companies are testing out orexin agonists to improve the symptoms of narcolpesy.
Via
Investor's Business Daily
Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study
↗
July 21, 2025
Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.
Via
Benzinga
Expert Outlook: Alkermes Through The Eyes Of 6 Analysts
↗
July 15, 2025
Via
Benzinga
Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit
↗
July 07, 2025
The company anticipates a research expense in Q2 associated with milestone and licensing payments, which will impact both GAAP and non-GAAP earnings per share.
Via
Stocktwits
ALKERMES PLC (NASDAQ:ALKS) – A Potential Undervalued Opportunity in Biopharma
↗
July 04, 2025
ALKERMES PLC (NASDAQ:ALKS) shows strong profitability and financial health while trading at a discount to peers, making it a potential value opportunity in biopharma.
Via
Chartmill
Nvidia To Rally More Than 38%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
June 17, 2025
Via
Benzinga
This Cooper Companies Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday
↗
June 17, 2025
Via
Benzinga
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
↗
June 17, 2025
Via
Benzinga
This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
May 28, 2025
Via
Benzinga
Beyond The Numbers: 6 Analysts Discuss Alkermes Stock
↗
April 28, 2025
Via
Benzinga
In a market where value is scarce, ALKERMES PLC (NASDAQ:ALKS) offers a refreshing opportunity with its solid fundamentals.
↗
April 17, 2025
ALKERMES PLC is a hidden gem, featuring undervaluation and robust fundamentals. NASDAQ:ALKS showcases decent financial health and profitability, coupled with an attractive price.
Via
Chartmill
What 5 Analyst Ratings Have To Say About Alkermes
↗
March 27, 2025
Via
Benzinga
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
↗
February 12, 2025
A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New...
Via
Benzinga
Topics
Economy
Alkermes Plc EPS Soars Past Forecasts
↗
February 12, 2025
Alkermes reported strong earnings by exceeding both revenue and earnings expectations in its latest quarterly release.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
